human neural stem cells hold great promise for research and therapy in neural disease. We describe the generation of integration-free and expandable human neural progenitor cells (nPcs). We combined an episomal system to deliver reprogramming factors with a chemically defined culture medium to reprogram epithelial-like cells from human urine into nPcs (huinPcs). these transgene-free huinPcs can selfrenew and can differentiate into multiple functional neuronal subtypes and glial cells in vitro. Although functional in vivo analysis is still needed, we report that the cells survive and differentiate upon transplant into newborn rat brain.
Several neural disorders have no effective drug treatment at present, and stem cells offer hope for those suffering from these debilitating diseases. There has been intense interest in obtaining human neural stem cells (NSCs) that may be used to treat neural disorders or to study them in the laboratory. The isolation and use of NSCs from either fetal or adult human tissue remain challenging because of ethical concerns and immune rejection 1, 2 . Induced pluripotent stem cell (iPSC) technology provides a promising solution to this problem because it may be used to generate patient-specific cells for autologous engraftment [3] [4] [5] [6] . Indeed, iPSCs from patients with neural diseases have been established successfully, such as with Parkinson's disease 7, 8 , Huntington's disease 7 and Alzheimer's disease 9 . Differentiation of such iPSCs along the neural lineage and modeling of disease in vitro could increase our mechanistic understanding of these diseases, enable drug screening and eventually provide functional cells for autologous transplantation. However, the differentiation of human iPSCs into NSCs is inefficient, time consuming and variable among different iPSC lines 6 . Moreover, pluripotent cells such as iPSCs pose the risk of teratomas when transplanted in vivo. To attempt to circumvent these problems, new approaches have been devised to convert one somatic cell type to another without full reprogramming to the pluripotent state. Notably, functional neurons, termed induced neurons, have been generated directly from fibroblasts by retroviral delivery of neural-specific transcription factors or microRNAs [10] [11] [12] [13] [14] [15] . The direct conversion approach has also been successfully applied to reprogram mouse fibroblasts into hepatocyte-like cells 16, 17 , cardiomyocytes 17 and pancreatic β cells 18 , using virally delivered reprogramming factors.
Generation of integration-free neural progenitor cells from cells in human urine
An attractive alternative to using induced neurons or iPSCderived neurons is to generate self-renewable NPCs from a patient's own somatic cells, and to do so avoiding viral integration of the genes encoding reprogramming factors. In this report, we describe the integration-free generation of hUiNPCs, human NPCs from epithelial-like cells in human urine. The cells could be expanded in vitro and differentiate into neuronal subtypes and astrocytes.
results

Generation of integration-free nPcs from human urine cells
We have recently shown that human urine contains live cells that can be efficiently reprogrammed into iPSCs 19 . In an effort to further improve this approach to derive naive iPSCs, we adopted integration-free and feeder-free methods to reprogram human urine cells (HUCs). We purified viable HUCs from the urine (Fig. 1a ) of a healthy 37-year-old male donor and transfected them with oriP/EBNA episomal vectors carrying a combination of reprogramming factors encoded by OCT4 (POU5F1), SOX2, SV40LT, KLF4 and microRNA cluster MIR302-367 through electroporation 20, 21 and cultured the transfected cells in defined basal medium containing FGF2 (ref. 22 ) and a cocktail of small molecules (5i) known to promote reprogramming: CHIR99021, PD0325901, A83-01, thiazovivin and DMH1 (refs. [23] [24] [25] [26] [27] [28] [29] . We observed that the transfected HUCs showed rapid morphological changes in these cultures. Notably, as early as day 12 postelectroporation, we began to observe the formation of compact colonies (Fig. 1b) . The average colony-forming efficiency was around 0.2% as determined from the initial number of HUCs used in each reprogramming experiment and was consistent for three different donors (n = 3, Supplementary Fig. 1 ). This is in sharp contrast to HUCs electroporated with the same episomal vectors but cultured in TeSR 22 , in which iPSC colonies appeared at around 25 d after electroporation ( Supplementary Fig. 2 ). We were intrigued by the appearance of these early colonies and characterized them further.
We picked colonies from both TeSR and 5i cultures and cultured them further on Matrigel, in their original media. Surprisingly, the domed colonies that had emerged in the 5i medium assumed a rosette-like morphology typical of NPCs (Fig. 1c) . In contrast, colonies grown in TeSR medium grew as typical human iPSC colonies ( Supplementary Fig. 2 ). We hypothesized that cells undergoing reprogramming in the 5i medium might preferentially commit to the NPC fate at an early stage (around day 12) before the establishment of a full pluripotent state (around day 25). To test this hypothesis, we randomly picked 20 individual colonies from the reprogramming culture in 5i at day 14 or 15 and examined the expression of NSC and pluripotency markers without further re-plating or culturing. By quantitative real-time PCR (qRT-PCR) analysis, we observed robust expression of typical NSC genes such as SOX2 and NES (encoding nestin) in all 20 colonies. We did not observe substantial activation of genes encoding pluripotency markers such as OCT4 and NANOG or other lineage markers such as T (brachyury) and SOX17 ( Fig. 1d and Supplementary Fig. 2 ). We did detect low expression of SOX17 in HUCs and some picked colonies, which is consistent with the endodermal origin of HUCs ( Supplementary Fig. 2 ). PAX6, another NSC gene, was activated at day 14, but more npg substantially so at day 15, which suggests a dynamic process of reprogramming toward a neural fate ( Fig. 1d) .
We further immunostained the 5i colonies at day 15 for known embryonic stem cell (ESC) or NSC markers. The colonies were negative for pluripotency markers such as TRA-1-60, TRA-1-81 and NANOG but stained positively for PAX6 and nestin ( Fig. 1e- 
i).
We also failed to detect substantial activation of OCT4 and NANOG at earlier stages of reprogramming (days 6-8) ( Supplementary Fig. 2 ). It has been reported that mouse embryonic fibroblasts reprogrammed with standard pluripotency factors (Oct4, Sox2, Klf4 and c-Myc) can be switched to a neural identity by transferring the virally infected cells to neural medium containing fibroblast growth factors and epidermal growth factor 30 . However, we did not observe NPC-like colonies among the transfected HUCs grown in the identical neural medium reported earlier (data not shown). npg Furthermore, when we replaced HUCs with human dermal fibroblasts, we observed no NPC-like cells under the conditions that we used for HUC reprogramming with 5i (data not shown). Taken together, our results suggest that the compact, dome-shaped colonies that appeared early during reprogramming in 5i medium may have committed to an NPC fate rather than a pluripotent one. We observed the same outcome for HUCs donated by two additional individuals ages 10 and 25 at an average reprogramming efficiency of around 0.2% based on the starting number of HUCs (Supplementary Fig. 1) .
To characterize the proliferative potential of hUiNPCs, we dissociated the re-plated rosette colonies and seeded them as single cells on Matrigel (Fig. 1j) . We observed that these cells grew well and exhibited typical NPC morphology. When cultured in suspension, the hUiNPCs grew as neural spheres, a typical property of NSCs 31 , and could be expanded over multiple passages with a high proliferation rate (Fig. 1k) . The cells expressed high levels of the proliferation marker Ki67 (Fig. 1l) . hUiNPC spheres expanded for 11 passages also showed homogenous expression (>90% of cells) of the neural ectoderm transcription factors PAX6 (ref. 32 ) and SOX1 as well as the neural stem cell markers SOX2 and nestin (Fig. 1m-o and Supplementary Fig. 2) . In contrast, we did not detect the expression of pluripotency markers such as OCT4 or markers for other germ layer lineages such as SOX17 and T (Fig. 1p,q and Supplementary Fig. 2) . The expanded hUiNPCs at passage 6 no longer harbored the reprogramming factors encoded by OCT4, SOX2, KLF4, SV40LT or MIR302-367, nor did they carry the genes from the episomal vector backbone ( Fig. 1r ), yet they possessed normal karyotypes (Fig. 1s) . We also performed whole-genome sequencing of select hUiNPCs and confirmed that they are of human origin (data not shown).
huinPcs show distinct gene expression profiles
We profiled the global gene expression patterns of hUiNPCs, the parental HUCs and the urine cell-derived iPSCs (Uri_iPSCs). The hUiNPCs clustered independently from the starting HUCs (UriC1 and UriC2) and the urine iPSCs (Uri_iPSC1, Uri_iPSC2) ( Fig. 2a) . Further paired-comparison analysis revealed distinct expression profiles between hUiNPCs and Uri_iPSCs derived from the same starting cells: neural genes were more highly expressed in hUiNPCs, and pluripotency genes were more highly expressed in Uri_iPSCs (Fig. 2b) . By comparing the expression profiles between HUCs and hUiNPCs, we identified 720 genes related to neuronal function that were upregulated in hUiNPCs (Fig. 2c,d and Supplementary Table 1) . In contrast, the HUC expression profiles were enriched for genes related to endothelial, angiogenic or epithelial functions (Fig. 2c,d and Supplementary  Table 2) , indicating that the HUCs might be of endothelial or epithelial origin.
huinPcs differentiate into cell subtypes of neural lineage
The promise of NPCs relies on their capacity to differentiate into functional subtypes of neural cells (Fig. 3) . We observed that hUiNPCs (at passage 5) could efficiently give rise to β III tubulin (TUJ1)-positive neurons (at an average efficiency of 76.7% of total cells in three experiments) and glial fibrillary acid protein (GFAP)positive astrocytes (at an average efficiency of 7.8% of total cells in three experiments) upon in vitro spontaneous differentiation ( Fig. 3a,b,l) . Moreover, this differentiation potential was well maintained throughout prolonged in vitro expansion (passage 8) (Fig. 3l) . Unlike mouse NPCs, human NPCs do not give rise to oligodendrocytes during spontaneous in vitro differentiation 33, 34 . However, in the presence (for 3 weeks) of factors (PDGF-AA, NT3, IGF1) known to promote oligodendrocyte differentiation, we observed O4-and PDGFR-α-positive oligodendrocyte-like cells (Fig. 3h,i) . We observed, by staining with neuronal subtype-specific markers, that hUiNPCs could generate various subtypes of neurons including mature glutamatergic, GABAergic and dopaminergic neurons at 37.6%, 15.2% and 6.5%, respectively ( Fig. 3e-g, respectively, and  Fig. 3k ). We also observed DCX-positive immature neurons in the differentiation culture (Fig. 3d) . Finally, 85.4% of neurons derived from hUiNPC were positive for synapsin, indicating that most of the neurons were likely to be excitable (Fig. 3j,k) .
huinPc-derived neurons are functional in vitro
We used standard whole-cell patch-clamp recordings to examine the function of hUiNPC-derived neurons (Fig. 4) . We observed rapidly inactivating inward currents and persistent outward currents in response to depolarizing voltage steps that could be blocked by tetrodotoxin and tetraethylammonium (Fig. 4b,c) .
We also observed that the neurons generated repetitive trains of action potentials (Fig. 4a) . Notably, the hUiNPC-derived neurons exhibited strong postsynaptic currents spontaneously or in response to excitatory or inhibitory neurotransmitter stimulation ( Fig. 4d-f ; 5 out of 5 neurons for each experiment).
Together, these data demonstrate that hUiNPCs can give rise to mature, functional neurons in vitro.
transplantation of huinPcs in vivo
To examine the potential of hUiNPCs in vivo, we transplanted these cells into the striatum of newborn rats (n = 12 rats) ( Fig. 5a) and analyzed the brains of the animals 4 weeks after transplantation. We observed human nuclear antigen (hNA)-stained cells that had survived and migrated in the host brain ( Fig. 5) and did not observe teratoma formation in any of the transplanted rats (Fig. 5a) . Some hNA-positive cells apparently remained as NPCs, as they stained positively for the NSC marker nestin ( Fig. 5b and  Supplementary Fig. 3 ). We also observed hNA-positive cells that expressed the astrocyte marker GFAP and the neuronal marker TUJ1 (Fig. 5b) , which indicated that the engrafted hUiNPCs could give rise to both neurons and astrocytes in vivo.
A full characterization of the stability, differentiation potential and function of these cells in vivo will require further study.
discussion
We describe here the notable finding that functional NPCs can be generated from somatic cells with the same factors known to be capable of reprogramming to pluripotency when cells are cultured in specially defined conditions. Recently, several reports have shown that mouse fibroblasts can be reprogrammed directly into neural stem cells using virally delivered reprogramming factors [35] [36] [37] [38] . In contrast, our method uses episomal factors for rapid and efficient derivation of integration-free NPCs from cells in human urine.
We showed that hUiNPCs arise at day 12-15, before the emergence of iPSCs at day 24-28 ( Fig. 1) . Further, the colonies express NSC markers, but we did not detect the expression of pluripotency markers (Fig. 1d-i) . However, on the basis of our current data, which were obtained from mixed populations of cells, we cannot rule out the possibility that some cells in the reprogramming culture pass through a fully pluripotent state. Single-cell analysis will help clarify this question 39, 40 and may also yield insight at the molecular level into how different cell fate decisions can be triggered in somatic cells by the same reprogramming factors.
We have applied our approach successfully to generate hUiN-PCs from three individuals at ages 10, 25 and 37 years, with an average reprogramming efficiency around 0.2% ( Supplementary  Fig. 1) . We envision that our protocols can be further applied to HUCs isolated from patients with neural disorders such as Parkinson's disease, Alzheimer's disease or other neurodegenerative diseases. These patient-specific hUiNPCs should be useful for modeling disease and for drug screening. hUiNPCs may in the future also prove useful for cell therapy, such as for patients with spinal cord injury. Our feeder-and serum-free culture system for generating these cells can enable this application. The overall efficiency of ~0.2% for the generation of hUiNPCs from HUCs is operationally adequate for current research, although future improvements to efficiency could be made, as has been accomplished for iPSC generation 41 .
methods Methods and any associated references are available in the online version of the paper.
Accession codes. The microarray data are available in the Gene Expression Omnibus database under the accession number GSE36395.
Note: Supplementary information is available in the online version of the paper.
online methods Isolation and culture of HUCs. Three donors were recruited for urine samples with informed consent based on IRB approval (no. GIBH-IRB02-2009002) at Guangzhou Institutes of Biomedicine and Health (GIBH). The procedures and purposes for isolating urine cells and generating stem cells were explained to the donors in detail, and questions, if any, were answered in full. We then obtained a formal signed consent form and collected a total of ~500 ml of urine from each donor. The subsequent procedures for isolating human urine cells and generating stem cells were performed as approved. The method for isolating urine cells was modified from a previous established protocol 19 . Briefly, urine samples were collected at the mid-stream from three individuals and centrifuged to collect the exfoliated cells. The primary urine cells were then processed and cultured in urine cell medium consisting of a 1: Supplementary Table 3 .
Analysis of gene integration by PCR.
Genomic DNAs were extracted using the Wizard Genomic DNA Purification Kit (Promega) for PCR analysis using primers ( Supplementary  Table 3 ) that specifically amplify the exogenous transgenes as described 20 .
Immunocytochemistry. Cells were fixed in 4% paraformaldehyde dissolved in 0.1 M phosphate buffer (PB) for 20 min. After several washes with 0.01 M phosphate-buffered saline (PBS), the cultures were incubated with the primary antibodies in PBS plus 1% BSA, 10% normal goat serum and 0.3% Triton X-100 overnight at 4 °C. The primary antibodies are listed in Supplementary  Table 4 . Primary antibodies were visualized with species-specific secondary antibody conjugated to the fluorescent labels Alexa 568 or 488 (1:400; Invitrogen). Cells were mounted in anti-fade medium containing 4′,6-diamidino-2-phenylindole (Sigma) to counterstain nuclei. At least 500 DAPI-positive cells from five randomly selected fields were counted to calculate the fraction of each lineage. Results are mean ± s.e.m. of data from three experiments unless stated otherwise in legends. Cells were imaged on a Zeiss Axio Imager A1 microscope or a Leica TCS SP2 Spectral confocal microscope.
Electrophysiological analysis.
Whole-cell patch-clamp recording techniques were used to study the physiological properties of hUiNPC-derived neurons in culture with borosilicate glass pipettes (resistance 5-10 MΩ) using an Axopatch 200B amplifier (Axon Instruments for Molecular Devices). Both the spontaneous postsynaptic current and current response to exogenous focal application of glutamate and GABA were recorded. Pressure ejection was used to puff 1 mM glutamate (10 p.s.i., 100 ms) and 1 mM GABA (10 p.s.i., 100 ms), and the holding voltages were −80 mV and 0 mV, respectively. The patch pipette internal solution contained (in mM): 136.5 K-gluconate, 0.2 EGTA, 10 HEPES, 9 NaCl, 17.5 KCl, 4 Mg-ATP and 0.3 Na-GTP, adjusted with KOH to pH 7.2, 285 osmol/l. For the recording of voltage-gated currents and action potentials, we used the following composition of the intracellular solution (in mM): 140 potassium methanesulfonate, 10 HEPES, 5 NaCl, 1 CaCl 2 , 0.2 EGTA, 3 ATP-Na 2 , 0.4 GTP-Na 2 , pH 7.3 (adjusted with KOH). The external solution contained (in mM): 120 NaCl, 1.2 KH 2 PO 4 , 1.9 KCl, 26 NaHCO 3 , 2.2 CaCl 2 , 1.4 MgSO 4 , 10 dglucose, 7.5 HEPES (pH with NaOH to 7.3). The bath solution was equilibrated with 95% O 2 and 5% CO 2 before use. Resting potentials were maintained at about −60 mV. Signals were sampled at 10 kHz using a Digidata1440A analog-to-digital converter and acquired and stored on a computer hard drive using pClamp10 software. Data were analyzed using pClamp10 (Clampfit).
Karyotype analysis. hUiNPCs were used for karyotype analysis as described 42 . Cells were grown in 10-cm plates, and demecolcine (Dahui Biotech) was added to a final concentration of 50 µg/ml for 40 min. Cells were then trypsinized, pelleted by centrifugation at 200g for 5 min, resuspended in 8 ml of 0.075 M KCl and incubated for 20 min at 37 °C. Fixative solution composed of one part acetic acid and three parts methanol was added to a final npg
